Table of Contents
2004 Annual Shareholders Meeting
Introduction Possis Executives
Special Guest
2004 Results and Future Goals
Forward-Looking Statements
FY 2004 Another Record-Breaking Year!
Sales Growth U.S. & International
A Healthy Gross Profit Margin
Three Full Fiscal Years of Increasing Profitability
Strong and Uncomplicated Balance Sheet
National Recognition for Possis Performance
Why all the Recent Recognition? Exceptional Three-Year Growth:
Possis Improves the Lives of the Patients We Serve
Success is a Marathon.
FY 2005 AiMI results have created one of those key points of struggle.
2005 First Quarter Results
Over 200,000 Catheters Sold!
Over 1400 AngioJet® Systems Worldwide 95% of the top US coronary labs have the AngioJet System!
Possis is the Leader in US Thrombectomy Markets
Targeted Strategies
FY05 Primary Objectives
Fiscal Year 2005 Revised Financial Goals
Marketing Overview and Goals
Coronary Artery Disease
Coronary Artery Disease
Coronary Artery Disease
Peripheral Arterial Disease
Peripheral Arterial Disease
Peripheral Arterial Disease
Dialysis Graft Maintenance
Dialysis Graft Maintenance
Dialysis Graft Maintenance
FY05 Realizable Market
New Market Opportunity: Venous Thrombosis
New Market Opportunity: Venous Thrombosis
New Market Opportunity: Venous Thrombosis
New Market Opportunity: Venous Thrombosis
New Market Opportunity: Embolic Protection
AngioJet® & GuardDOG™
Realizable Markets Growing
Strategic Marketing Objectives for FY2005
Distribution Post AiMI
Possis US World Class Sales Organization
OUS Possis Distribution
#1 Priority Putting AiMI in Perspective
PPT Slide
PPT Slide
AiMI…What Gives?
#1 Priority Putting AiMI in Perspective
PPT Slide
PPT Slide
#1 Priority Putting AiMI in Perspective
Additional Coronary References
#1 Priority Putting AiMI in Perspective
Potential Future Coronary Data Points
Conclusion
Visit us at www.possis.com
|